The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ELCC 2022 | Developing clinical guidelines for the treatment of patients with thymic epithelial tumors
Jordi Remon, MD, PhD, HM CIOCC – Centro Integral Oncológico Clara Campal, Barcelona, Spain, talks on the development of unifying clinical guidelines for thymic epithelial tumors, including the role of surgery and postoperative treatment with radiotherapy or chemotherapy for early-stage disease and treatment approaches for locally advanced and metastatic disease. Dr Remon and colleagues recently published guidelines in Spain, with the aim of standardizing the treatment of patients with thymic epithelial tumors. This interview took place during the virtual European Lung Cancer Congress 2022.
